Halaman, Krizza Marie B.
HRN: 23-06-59 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/03/2024
CEFUROXIME 750MG (VIAL)
03/03/2024
03/10/2024
IVT
750 Mg
Q8h
Multiple Abrasion
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes